<DOC>
<DOCNO>EP-0658099</DOCNO> 
<TEXT>
<INVENTION-TITLE>
ANTI-FREE-RADICAL TOPICAL COMPOSITION BASED ON A SUPEROXIDE DISMUTASE AND A PHOSPHONIC DERIVATIVE
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K858	A61P4300	A61K896	A61Q1908	A61Q502	A61K830	A61Q1704	A61P1700	A61P1700	A61K800	A61K892	A61Q502	A61Q1700	A61Q1704	A61Q500	A61K3844	A61K800	A61K3166	A61K866	A61Q500	A61Q1908	A61Q1900	A61K872	A61K3166	A61K872	A61Q1900	A61K896	A61K3843	A61Q700	A61Q1700	A61K855	A61P4300	A61K892	A61Q700	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61P	A61K	A61Q	A61Q	A61K	A61Q	A61P	A61P	A61K	A61K	A61Q	A61Q	A61Q	A61Q	A61K	A61K	A61K	A61K	A61Q	A61Q	A61Q	A61K	A61K	A61K	A61Q	A61K	A61K	A61Q	A61Q	A61K	A61P	A61K	A61Q	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K8	A61P43	A61K8	A61Q19	A61Q5	A61K8	A61Q17	A61P17	A61P17	A61K8	A61K8	A61Q5	A61Q17	A61Q17	A61Q5	A61K38	A61K8	A61K31	A61K8	A61Q5	A61Q19	A61Q19	A61K8	A61K31	A61K8	A61Q19	A61K8	A61K38	A61Q7	A61Q17	A61K8	A61P43	A61K8	A61Q7	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
OREAL
</APPLICANT-NAME>
<APPLICANT-NAME>
L'OREAL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
GALEY JEAN-BAPTISTE
</INVENTOR-NAME>
<INVENTOR-NAME>
N GUYEN QUANG LAN
</INVENTOR-NAME>
<INVENTOR-NAME>
GALEY, JEAN-BAPTISTE
</INVENTOR-NAME>
<INVENTOR-NAME>
N'GUYEN, QUANG LAN
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Cosmetic or pharmaceutical composition intended 
for a topical use, characterized in that it comprises at 

least one superoxide dismutase in combination with at 
least one phosphonic acid derivative or one of its salts. 
Composition according to Claim 1, characterized 
in that the superoxide dismutase and the phosphonic 

derivative are present in a ratio by weight of between 2 
and 25 %. 
Composition according to Claim 1 or 2, 
characterized in that the superoxide dismutase is present 

in the proportion of 0.001 to 4 % by weight and 
preferably of 0.75 to 1.7 % by weight with respect to the 

total weight of the composition. 
Composition according to any one of Claims 1 to 
3, characterized in that the phosphonic derivative is 

present in the proportion of 0.005 to 2 % by weight and 
preferably of 0.05 to 0.1 % by weight with respect to the 

total weight of the composition. 
Composition according to any one of Claims 1 to 
4, characterized in that the superoxide dismutase is of 

animal, human, bacterial, yeast, plant or marine origin 
or obtained by biotechnology. 
Composition according to any one of Claims 1 to 
5, characterized in that the superoxide dismutase 

contains iron, contains manganese or contains copper-zinc. 
Composition according to any one of Claims 1 to 
6, characterized in that the polyphosphonic derivative is 

chosen from ethylenediaminetetra(methylenephosphonic)  
 

acid, hexamethylenediaminetetra(methylenephosphonic) 
acid, diethylenetriaminepenta(methylenephosphonic) acid, 

1-hydroxyethylidene-1,1-diphosphonic acid and aminotri(methylenephosphonic) 
acid and preferably from ethylenediaminetetra(methylenephosphonic) 

acid and diethylenetriaminepenta(methylenephosphonic) 
acid, and their salts. 
Composition according to any one of Claims 1 to 
7, character
ized in that the salts are chosen from those 
of ammonium and of alkali metals, preferably of sodium. 
Composition according to any one of Claims 1 to 
8, characterized in that it is in the form of a lotion, 

an emulsion, a milk, microspheres, microgranules, a 
cream, a gel, a balm or an aerosol spray, or vesiculas of 

ionic or non-ionic type. 
Composition according to any one of Claims 1 to 
9, characterized in that it additionally contains at 

least one cosmetic ingredient chosen from surfactants, 
dyes, fragrances, preserving agents, emulsifiers, liquid 

vehicles, fatty substances, resins and waxes. 
Use of at least one superoxide dismutase in 
combination with at least one phosphonic derivative, 

preferably chosen from ethylenediaminetetra(methylenephosphonic) 
acid, hexamethylenediaminetetra(methylenephosphonic) 

acid, diethylenetriaminepenta(methylenephosphonic) 
acid, 1-hydroxyethylidene-1,1-diphosphonic 

acid and aminotri(methylenephosphonic) acid, and their 
salts, in the preparation of a cosmetic composition 

intended for the treatment of the skin. 
Cosmetic treatment process for the purpose of 
improving the aesthetic appearance of the skin, 

characterized in that a cosmetic composition according to 
Claims 1 to 10 is supplied to the skin. 
</CLAIMS>
</TEXT>
</DOC>
